Impact of Intraoperative Hemodynamic Instability on Outcomes in Cardiac Surgery

NCT ID: NCT07324694

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

230 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-26

Study Completion Date

2026-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intraoperative hemodynamic instability (IOHI) is a common occurrence during cardiac surgery and is associated with organ hypoperfusion. However, the specific impact of IOHI on composite adverse outcomes remains unclear. This prospective cohort study aims to evaluate the association between intraoperative hemodynamic instability (defined as MAP \< 65 mmHg or vasopressor requirement) and major postoperative complications (Delirium, Acute Kidney Injury, Stroke, or Mortality) in adult patients undergoing elective cardiac surgery with cardiopulmonary bypass.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hemodynamic instability during cardiac surgery is a critical factor influencing postoperative recovery. While transient hypotension is common, prolonged instability may lead to end-organ damage due to hypoperfusion. This prospective observational study will be conducted at the University of Health Sciences Gazi Yasargil Training and Research Hospital.

Patients scheduled for elective cardiac surgery (Coronary Artery Bypass Grafting, Valve replacement/repair, or combined procedures) utilizing cardiopulmonary bypass will be enrolled. Intraoperative hemodynamic data, including Mean Arterial Pressure (MAP), heart rate, and vasoactive medication requirements, will be recorded.

Patients will be categorized into two groups based on intraoperative stability:

1. Hemodynamic Instability Group: Patients experiencing MAP \< 65 mmHg for more than 5 minutes continuously or requiring significant vasopressor/inotropic support to maintain target pressure.
2. Stable Group: Patients maintaining hemodynamic stability without significant hypotensive episodes.

The primary endpoint is a composite of major adverse events within 30 days, including Postoperative Delirium (assessed via CAM-ICU), Acute Kidney Injury (KDIGO criteria), Stroke, and All-cause Mortality. Secondary endpoints include the duration of mechanical ventilation and length of ICU/hospital stay. The study aims to provide evidence-based thresholds for intraoperative blood pressure management to improve patient outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Surgery Intraoperative Hemodynamic Instability Postoperative Complication Acute Kidney Injury Postoperative Delirium (POD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemodynamic Instability Group

Patients who exhibit intraoperative hemodynamic instability, defined as Mean Arterial Pressure (MAP) \< 65 mmHg for \>5 minutes continuously, or requiring vasopressor/inotropic support to maintain MAP.

No interventions assigned to this group

Hemodynamically Stable Group

Patients who maintain intraoperative hemodynamic stability without significant hypotension episodes (MAP \> 65 mmHg) or vasopressor requirement beyond baseline anesthesia induction.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 years or older.
* Scheduled for elective cardiac surgery (CABG, Valve replacement/repair, or combined procedures).
* Surgery performed under cardiopulmonary bypass (CPB).
* Preoperative sinus rhythm.
* Signed informed consent form.

Exclusion Criteria

* Emergency or salvage surgery.
* Off-pump coronary artery bypass grafting.
* Preoperative mechanical circulatory support (IABP, ECMO) requirement.
* Pre-existing chronic renal failure requiring dialysis (HD/PD).
* Pre-existing cognitive impairment, dementia, or history of psychiatric disorders affecting cooperation.
* Pregnancy.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Osman Uzundere

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gazi Yaşargil Training and Research Hospital

Diyarbakır, Diyarbakır, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Osman Uzundere, M.D.

Role: CONTACT

+905330206362

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Osman Uzundere, M.D.

Role: primary

+905330206362

References

Explore related publications, articles, or registry entries linked to this study.

Shen X, Tao H, Chen W, Sun J, Jin R, Zhang W, Hong L, Zhang C. Perioperative blood pressure variability as a risk factor for postoperative delirium in the patients receiving cardiac surgery. BMC Anesthesiol. 2024 Nov 25;24(1):424. doi: 10.1186/s12871-024-02817-x.

Reference Type RESULT
PMID: 39581994 (View on PubMed)

D'Amico F, Fominskiy EV, Turi S, Pruna A, Fresilli S, Triulzi M, Zangrillo A, Landoni G. Intraoperative hypotension and postoperative outcomes: a meta-analysis of randomised trials. Br J Anaesth. 2023 Nov;131(5):823-831. doi: 10.1016/j.bja.2023.08.026. Epub 2023 Sep 20.

Reference Type RESULT
PMID: 37739903 (View on PubMed)

Buitenwerf E, Boekel MF, van der Velde MI, Voogd MF, Kerstens MN, Wietasch GJKG, Scheeren TWL. The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability. Eur J Anaesthesiol. 2019 Apr;36(4):290-296. doi: 10.1097/EJA.0000000000000941.

Reference Type RESULT
PMID: 30624247 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GYTRH-KVC-IOHI-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vasoplegic Syndrome in Cardiac Surgery
NCT03281317 ACTIVE_NOT_RECRUITING